Vertex (VRTX) Q4 Earnings Beat on Strong CF Products Sales
Vertex Pharmaceuticals Incorporated VRTX reported fourth-quarter 2017 earnings per share of 61 cents, which beat the Zacks Consensus Estimate of 58 cents and came ahead of the year-ago earnings of 35 cents. Strong product revenues led to higher profits in the quarter and lower operating expense ratio year over year. […]